HuGE Literature Finder
|
||
Records 1-55
|
Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers.
Cancer 2019 Oct . Song Yun, Barry William T, Seah Davinia S, Tung Nadine M, Garber Judy E, Lin Nancy |
|
Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in
Cancers 2019 May 11 (6): . Vocka Michal, Zimovjanova Martina, Bielcikova Zuzana, Tesarova Petra, Petruzelka Lubos, Mateju Martin, Krizova Ludmila, Kotlas Jaroslav, Soukupova Jana, Janatova Marketa, Zemankova Petra, Kleiblova Petra, Novotny Jan, Konopasek Bohuslav, Chodacka Martina, Brychta Milan, Sochor Marek, Smejkalova-Musilova Denisa, Cmejlova Vlastimila, Kozevnikovova Renata, Miskarova Lenka, Argalacsova Sona, Stolarova Lenka, Lhotova Klara, Borecka Marianna, Kleibl Zden |
|
Prevalence of germline variants in inflammatory breast cancer.
Cancer 2019 Apr . Rana Huma Q, Sacca Rosalba, Drogan Christine, Gutierrez Stephanie, Schlosnagle Emily, Regan Meredith M, Speare Virginia, LaDuca Holly, Dolinsky Jill, Garber Judy E, Overmoyer Beth |
|
Risk of ipsilateral breast tumor recurrence in primary invasive breast cancer following breast-conserving surgery with BRCA1 and BRCA2 mutation in China.
Breast cancer research and treatment 2019 Mar . Cao Wei, Xie Yuntao, He Yingjian, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Ouyang T |
|
BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
Molecular genetics & genomic medicine 2019 Jan . Liu Yan, Ide Yoshimi, Inuzuka Mayuko, Tazawa Sakiko, Kanada Yoko, Matsunaga Yuki, Kuwayama Takashi, Sawada Terumasa, Akashi-Tanaka Sadako, Nakamura Sei |
|
BRCA1/BRCA2 Mutations Shaped by Ancient Consanguinity Practice in Southern Mediterranean Populations
Asian Pacific journal of cancer prevention : APJCP 2018 Oct 19 (10): 2963-2972. Belaiba Fadoua, Medimegh Imene, Bidet Yannick, Boussetta Sami, Baroudi Olfa, Mezlini Amel, Bignon Yves Jean, Benammar El gaaied Am |
|
Subsequent breast and high grade serous carcinomas after risk-reducing salpingo-oophorectomy in BRCA mutation carriers and patients with history of breast cancer.
Annals of diagnostic pathology 2018 Jun 36 28-30. Straub Melissa M, Podoll Mirna B, David Stephanie N, Wiesner Georgia L, Desouki Mohamed |
|
The role of PARP inhibition in triple-negative breast cancer: Unraveling the wide spectrum of synthetic lethality.
Cancer treatment reviews 2018 May 67 34-44. Papadimitriou Marios, Mountzios Giannis, Papadimitriou Christos |
|
Frequency of pathogenic germline mutations in cancer susceptibility genes in breast cancer patients.
Medical oncology (Northwood, London, England) 2018 Apr 35 (6): 81. Kaur Raman Preet, Shafi Gowhar, Benipal Raja Paramjeet Singh, Munshi Anja |
|
Germline breast cancer susceptibility gene mutations and breast cancer outcomes.
BMC cancer 2018 Mar 18 (1): 315. Wang Yong Alison, Jian Jhih-Wei, Hung Chen-Fang, Peng Hung-Pin, Yang Chi-Fan, Cheng Hung-Chun Skye, Yang An-Su |
|
Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study.
The Lancet. Oncology 2018 Jan . Copson Ellen R, Maishman Tom C, Tapper Will J, Cutress Ramsey I, Greville-Heygate Stephanie, Altman Douglas G, Eccles Bryony, Gerty Sue, Durcan Lorraine T, Jones Louise, Evans D Gareth, Thompson Alastair M, Pharoah Paul, Easton Douglas F, Dunning Alison M, Hanby Andrew, Lakhani Sunil, Eeles Ros, Gilbert Fiona J, Hamed Hisham, Hodgson Shirley, Simmonds Peter, Stanton Louise, Eccles Diana |
|
The Use of Sentinel Lymph Node Biopsy in BRCA1/2 Mutation Carriers Undergoing Prophylactic Mastectomy: A Retrospective Consecutive Case-Series Study.
International journal of breast cancer 2018 2018 1426369. Câmara Sara, Pereira Daniela, André Saudade, Mira Beatriz, Vaz Fátima, Oom Rodrigo, Marques José Carlos, Leal de Faria João, Rodrigues Dos Santos Catari |
|
Young Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlates.
Journal of gynecologic oncology 2017 Jun . Helpman Limor, Zidan Omri, Friedman Eitan, Kalfon Sarit, Perri Tamar, Ben-Baruch Gilad, Korach Jac |
|
Early onset breast cancer in Ashkenazi women carriers of founder BRCA1/2 mutations: beyond 10 years of follow-up.
European journal of cancer care 2016 Oct . Dagan E, Gershoni-Baruch R, Kurolap A, Fried |
|
Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis.
Medicine 2016 Oct 95 (40): e4975. Baretta Zora, Mocellin Simone, Goldin Elena, Olopade Olufunmilayo I, Huo Dezhe |
|
Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutations.
Breast cancer research and treatment 2016 May . Lewin R, Sulkes A, Shochat T, Tsoref D, Rizel S, Liebermann N, Hendler D, Neiman V, Ben-Aharon I, Friedman E, Paluch-Shimon S, Margel D, Kedar I, Yerushalmi |
|
Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy.
Cancer 2016 Apr . Matulonis Ursula A, Harter Philipp, Gourley Charlie, Friedlander Michael, Vergote Ignace, Rustin Gordon, Scott Clare, Meier Werner, Shapira-Frommer Ronnie, Safra Tamar, Matei Daniela, Fielding Anitra, Spencer Stuart, Parry David, Grinsted Lynda, Ledermann Jonathan |
|
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer.
Breast cancer research and treatment 2016 Apr . Drooger Jan C, Heemskerk-Gerritsen Bernadette A M, Smallenbroek Nyrée, Epskamp Cynthia, Seynaeve Caroline M, Jager Agn |
|
BRCA testing, treatment patterns and survival in platinum-sensitive recurrent ovarian cancer - an observational cohort study.
Journal of ovarian research 2016 Mar 9 18. Unni Sudhir K, Schauerhamer Marisa B, Deka Rishi, Tyczynski Jerzy E, Fernandes Ancilla W, Stevens Vanessa, Brixner Diana I, Stenehjem David |
|
Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes.
PloS one 2016 11 (10): e0164370. Abáigar María, Robledo Cristina, Benito Rocío, Ramos Fernando, Díez-Campelo María, Hermosín Lourdes, Sánchez-Del-Real Javier, Alonso Jose M, Cuello Rebeca, Megido Marta, Rodríguez Juan N, Martín-Núñez Guillermo, Aguilar Carlos, Vargas Manuel, Martín Ana A, García Juan L, Kohlmann Alexander, Del Cañizo M Consuelo, Hernández-Rivas Jesús |
|
Invasion Patterns of Metastatic Extrauterine High-grade Serous Carcinoma With BRCA Germline Mutation and Correlation With Clinical Outcomes.
The American journal of surgical pathology 2015 Nov . Hussein Yaser R, Ducie Jennifer A, Arnold Angela G, Kauff Noah D, Vargas-Alvarez Hebert A, Sala Evis, Levine Douglas A, Soslow Robert |
|
Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age.
Breast cancer research and treatment 2015 Oct . Drooger Jan C, Akdeniz Delal, Pignol Jean-Philippe, Koppert Linetta B, McCool Danielle, Seynaeve Caroline M, Hooning Maartje J, Jager Agn |
|
The RAD51 135G>C polymorphism is related to the effect of adjuvant therapy in early breast cancer.
Journal of cancer research and clinical oncology 2015 May 141 (5): 797-804. Söderlund Leifler K, Asklid A, Fornander T, Stenmark Askmalm |
|
Prevalence of BRCA1 mutations and responses to neoadjuvant chemotherapy among BRCA1 carriers and non-carriers with triple-negative breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 Mar 26 (3): 523-8. Wang C, Zhang J, Wang Y, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie |
|
Nipple-sparing mastectomy in BRCA1/2 mutation carriers: an interim analysis and review of the literature.
Annals of surgical oncology 2015 Feb 22 (2): 370-6. Yao Katharine, Liederbach Erik, Tang Rong, Lei Lan, Czechura Tomasz, Sisco Mark, Howard Michael, Hulick Peter J, Weissman Scott, Winchester David J, Coopey Suzanne B, Smith Barbara |
|
Whole-exome sequencing of muscle-invasive bladder cancer identifies recurrent mutations of UNC5C and prognostic importance of DNA repair gene mutations on survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Dec 20 (24): 6605-17. Yap Kai Lee, Kiyotani Kazuma, Tamura Kenji, Antic Tatjana, Jang Miran, Montoya Magdeline, Campanile Alexa, Yew Poh Yin, Ganshert Cory, Fujioka Tomoaki, Steinberg Gary D, O'Donnell Peter H, Nakamura Yusu |
|
Prostate cancer screening characteristics in men with BRCA1/2 mutations attending a high-risk prevention clinic.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2014 Nov 8 (11-12): E783-8. Walker Richard, Louis Alyssa, Berlin Alejandro, Horsburgh Sheri, Bristow Robert G, Trachtenberg Jo |
|
High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer.
Breast cancer research and treatment 2014 Oct 147 (3): 571-8. Nilsson Martin P, Hartman Linda, Kristoffersson Ulf, Johannsson Oskar T, Borg Ake, Henriksson Karin, Lanke Elsa, Olsson Håkan, Loman Nikl |
|
Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations.
Gynecologic oncology 2014 Feb 132 (2): 280-6. Conner James R, Meserve Emily, Pizer Ellen, Garber Judy, Roh Michael, Urban Nicole, Drescher Charles, Quade Bradley J, Muto Michael, Howitt Brooke E, Pearlman Mark D, Berkowitz Ross S, Horowitz Neil, Crum Christopher P, Feltmate Colle |
|
The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation.
Breast cancer research and treatment 2013 Nov 142 (1): 177-85. Valentini Adriana, Lubinski Jan, Byrski Tomasz, Ghadirian Parviz, Moller Pal, Lynch Henry T, Ainsworth Peter, Neuhausen Susan L, Weitzel Jeffrey, Singer Christian F, Olopade Olufunmilayo I, Saal Howard, Lyonnet Dominique Stoppa, Foulkes William D, Kim-Sing Charmaine, Manoukian Siranoush, Zakalik Dana, Armel Susan, Senter Leigha, Eng Charis, Grunfeld Eva, Chiarelli Anna M, Poll Aletta, Sun Ping, Narod Steven A, |
|
Association between BRCA Mutation Status, Pathological Findings, and Magnetic Resonance Imaging Features in Patients with Breast Cancer at Risk for the Mutation.
Journal of breast cancer 2013 Sep 16 (3): 308-14. Noh Jae Myoung, Han Boo-Kyung, Choi Doo Ho, Rhee Sun Jung, Cho Eun Yoon, Huh Seung Jae, Park Won, Park Hyojung, Nam Seok Jin, Lee Jeong Eon, Kil Won- |
|
Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy.
Gynecologic oncology 2013 Feb . Powell CB, Swisher EM, Cass I, McLennan J, Norquist B, Garcia RL, Lester J, Karlan BY, Chen L |
|
53BP1 expression in sporadic and inherited ovarian carcinoma: Relationship to genetic status and clinical outcomes.
Gynecologic oncology 2012 Dec . Pennington KP, Wickramanayake A, Norquist BM, Pennil CC, Garcia RL, Agnew KJ, Taniguchi T, Welcsh P, Swisher EM |
|
BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Jul 30 (21): 2654-63. Alsop Kathryn, Fereday Sian, Meldrum Cliff, deFazio Anna, Emmanuel Catherine, George Joshy, Dobrovic Alexander, Birrer Michael J, Webb Penelope M, Stewart Colin, Friedlander Michael, Fox Stephen, Bowtell David, Mitchell Gilli |
|
Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Jan 30 (1): 19-26. Goodwin Pamela J, Phillips Kelly-Anne, West Dee W, Ennis Marguerite, Hopper John L, John Esther M, O'Malley Frances P, Milne Roger L, Andrulis Irene L, Friedlander Michael L, Southey Melissa C, Apicella Carmel, Giles Graham G, Longacre Teri |
|
Response to neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers: a single-institution experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Oct 29 (28): 3739-46. Arun Banu, Bayraktar Soley, Liu Diane D, Gutierrez Barrera Angelica M, Atchley Deann, Pusztai Lajos, Litton Jennifer Keating, Valero Vicente, Meric-Bernstam Funda, Hortobagyi Gabriel N, Albarracin Constan |
|
Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers.
Cancer 2011 Jul 117 (14): 3093-100. Lee Larissa J, Alexander Brian, Schnitt Stuart J, Comander Amy, Gallagher Bridget, Garber Judy E, Tung Nadi |
|
RAD51 increased expression as a predictor of outcome in patients with breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 May 29 (15_suppl): e21106. Parrella P, Latiano T P, Murgo R, D'Addetta C, Barbano R, Copetti M, Valori V M, Pellegrini F, Fazio V M, Maiello |
|
Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Mar 17 (5): 1082-9. Gonzalez-Angulo Ana M, Timms Kirsten M, Liu Shuying, Chen Huiqin, Litton Jennifer K, Potter Jennifer, Lanchbury Jerry S, Stemke-Hale Katherine, Hennessy Bryan T, Arun Banu K, Hortobagyi Gabriel N, Do Kim-Anh, Mills Gordon B, Meric-Bernstam Fun |
|
Effect of BRCA1/2 mutation on short-term and long-term breast cancer survival: a systematic review and meta-analysis.
Breast cancer research and treatment 2010 Jul 122 (1): 11-25. Lee Eun-Ha, Park Sue K, Park Boyoung, Kim Sung-Won, Lee Min Hyuk, Ahn Sei Hyun, Son Byung Ho, Yoo Keun-Young, Kang Daehee, , |
|
Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy.
Breast cancer research and treatment 2010 Jun 121 (2): 389-98. Pierce Lori J, Phillips Kelly-Anne, Griffith Kent A, Buys Saundra, Gaffney David K, Moran Meena S, Haffty Bruce G, Ben-David Merav, Kaufman Bella, Garber Judy E, Merajver Sofia D, Balmaña Judith, Meirovitz Amichay, Domchek Susan |
|
Germline BRCA mutations denote a clinicopathologic subset of prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010 Apr 16 (7): 2115-21. Gallagher David J, Gaudet Mia M, Pal Prodipto, Kirchhoff Tomas, Balistreri Lisa, Vora Kinjal, Bhatia Jasmine, Stadler Zsofia, Fine Samson W, Reuter Victor, Zelefsky Michael, Morris Michael J, Scher Howard I, Klein Robert J, Norton Larry, Eastham James A, Scardino Peter T, Robson Mark E, Offit Kenne |
|
Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature.
Breast cancer research and treatment 2009 Dec . Kirova YM, Savignoni A, Sigal-Zafrani B, de La Rochefordiere A, Salmon RJ, This P, Asselain B, Stoppa-Lyonnet D, Fourquet A |
|
Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants.
Cancer prevention research (Philadelphia, Pa.) 2009 Jul 2 (7): 617-24. Wu Xifeng, Spitz Margaret R, Lee J Jack, Lippman Scott M, Ye Yuanqing, Yang Hushan, Khuri Fadlo R, Kim Edward, Gu Jian, Lotan Reuben, Hong Waun |
|
A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population.
BMC cancer 2009 9 (1): 245. Palomba Grazia, Loi Angela, Uras Antonella, Fancello Patrizia, Piras Giovanna, Gabbas Attilio, Cossu Antonio, Budroni Mario, Contu Antonio, Tanda Francesco, Farris Antonio, Orrù Sandra, Floris Carlo, Pisano Marina, Lovicu Mario, Santona Maria Cristina, Landriscina Gennaro, Crisponi Laura, Palmieri Giuseppe, Monne Mar |
|
"BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 Dec 26 (34): 5530-6. Tan David S P, Rothermundt Christian, Thomas Karen, Bancroft Elizabeth, Eeles Rosalind, Shanley Susan, Ardern-Jones Audrey, Norman Andrew, Kaye Stanley B, Gore Martin |
|
Impaired tamoxifen metabolism reduces survival in familial breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Sep 14 (18): 5913-8. Newman William G, Hadfield Kristen D, Latif Ayshe, Roberts Stephen A, Shenton Andrew, McHague Christopher, Lalloo Fiona, Howell Sacha, Evans D Gare |
|
The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified.
Breast cancer research and treatment 2008 Jul 110 (1): 99-109. Li Wen-Feng, Hu Zhen, Rao Nan-Yan, Song Chuang-Gui, Zhang Bin, Cao Ming-Zhi, Su Feng-Xi, Wang Yong-Sheng, He Ping-Qing, Di Gen-Hong, Shen Kun-Wei, Wu Jiong, Lu Jin-Song, Luo Jian-Min, Liu Xiao-Yi, Zhou Jie, Wang Lei, Zhao Lin, Liu Yan-Bing, Yuan Wen-Tao, Yang Lin, Shen Zhen-Zhou, Huang Wei, Shao Zhi-Mi |
|
Novel sequence variants and a high frequency of recurrent polymorphisms in BRCA1 gene in Sri Lankan breast cancer patients and at risk individuals.
BMC cancer 2008 8 (1): 214. De Silva Wasanthi, Karunanayake Eric H, Tennekoon Kamani H, Allen Marie, Amarasinghe Indrani, Angunawala Preethika, Ziard Mohamed |
|
Origin and distribution of the BRCA2-8765delAG mutation in breast cancer.
BMC cancer 2007 7 (1): 132. Palomba Grazia, Cossu Antonio, Friedman Eitan, Budroni Mario, Farris Antonio, Contu Antonio, Pisano Marina, Baldinu Paola, Sini Maria C, Tanda Francesco, Palmieri Giusep |
|
Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy.
European journal of cancer (Oxford, England : 1990) 2005 Oct 41 (15): 2304-11. Kirova Youlia M, Stoppa-Lyonnet Dominique, Savignoni Alexia, Sigal-Zafrani Brigitte, Fabre Nicolas, Fourquet Alain, |
|
Prognostic impact of BRCA1 pathogenic and BRCA1/BRCA2 unclassified variant mutations in patients with ovarian carcinoma.
Cancer 2005 Sep 104 (5): 1004-12. Majdak EJ, Debniak J, Milczek T, Cornelisse CJ, Devilee P, Emerich J, Jassem J, De Bock GH |
|
The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers.
Gynecologic oncology 2005 Jan 96 (1): 222-6. Metcalfe Kelly A, Lynch Henry T, Ghadirian Parviz, Tung Nadine, Olivotto Ivo A, Foulkes William D, Warner Ellen, Olopade Olufunmilayo, Eisen Andrea, Weber Barbara, McLennan Jane, Sun Ping, Narod Steven |
|
Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases.
BMC cancer 2005 5 (): 70. Veronesi Andrea, de Giacomi Clelia, Magri Maria D, Lombardi Davide, Zanetti Martina, Scuderi Cristina, Dolcetti Riccardo, Viel Alessandra, Crivellari Diana, Bidoli Ettore, Boiocchi Mau |
|
Survival and recurrence after breast cancer in BRCA1/2 mutation carriers.
Annals of surgical oncology 2004 Feb 11 (2): 157-64. El-Tamer Mahmoud, Russo Donna, Troxel Andrea, Bernardino Lourdes P, Mazziotta Robert, Estabrook Alison, Ditkoff Beth-Ann, Schnabel Freya, Mansukhani Mahe |
- Page last reviewed:Jul 30, 2019
- Page last updated:Nov 14, 2019
- Content source: